Andres JM Ferreri, MD1, Silvia Govi, M.D.1*, Giuseppina Patrizia Dognini, M.D.2*, Maria Bouzani, M.D.3*, Claudia Ruth Bollinguer, M.D.4*, Michel D'Incan, M.D.5*, Emmanuel Delaporte, M.D.6*, Mehdi Hamadani, M.D.7*, Fabrice Jardin, M.D.8*, Magdalena Martusewicz-Boros, M.D.9*, Mauro Montanari, M.D.10*, Arpad Szomor, M.D.11*, Roberto Crocchiolo, M.D.1*, Emanuele Zucca, M.D.12*, Franco Cavalli, M.D.12* and Maurilio Ponzoni, M.D.13*
1Unit of Lymphoid Malignancies, Department of Oncology, Istituto Scientifico San Raffaele, Milano, Italy
2Medicina I, Azienda Ospedaliera Treviglio-Caravaggio, Treviglio, Italy
3Evangelismos Hospital, Athens, Greece
4University Hospital of Essen, Essen, Germany
5CHU-Hotel-Dieu, Clermont-Ferrand, France
6CHU-Lille, Lille, France
7Division of Hematology/Oncology, Ohio State University, Columbus, OH
8Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France
9National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
10Azienda Ospedali Riuniti di Ancona, Ancona, Italy
11Medicine Department University of Pecs, Pecs, Hungary
12Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
13Unit of Lymphoid Malignancies, Pathology Unit, Istituto Scientifico San Raffaele, Milano, Italy